(Q33720137)

English

Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents

scientific article published on September 21, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Neo-tanshinlactone inspired synthesis, in vitro evaluation of novel substituted benzocoumarin derivatives as potent anti-breast cancer agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Kamini Srivastava

6

object named as

Kamini Srivastava

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20951035

3 August 2024

author name string

Manoj Kumar

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Rishi Kumar Gara

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Lakshma Vadithe Nayak

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Hemant Kumar Bid

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Rituraj Konwar

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Koneni V. Sashidhara

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20951035

3 August 2024

Jammikuntla N. Rosaiah

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20951035

3 August 2024

language of work or name

0 references

publication date

21 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0960894X10013314?httpAccept=text/xml

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

https://api.elsevier.com/content/article/PII:S0960894X10013314?httpAccept=text/plain

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7127-7131

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Biochimica et Biophysica Acta

1

1

1552

author name string

Polyak

publication date

2001

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Gaining ground on breast cancer

2

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Focus on breast cancer

3

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents

4

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Aromatase inhibitors in the treatment of advanced breast cancer

5

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium

6

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Use of tamoxifen for breast cancer: twenty-eight years later

7

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

8

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

9

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

10

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Chemical library and structure-activity relationships of 11-demethyl-12-oxo calanolide A analogues as anti-HIV-1 agents.

11

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces

12

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antimycobacterial coumarins from the sardinian giant fennel (Ferula communis).

13

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage

14

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities

15

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

A review of coumarin derivatives in pharmacotherapy of breast cancer

16

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase

17

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.

18

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Cancer Research

19

62

1439

author name string

Brady

publication date

2002

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90.

20

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor

21

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antitumor agents. 266. Design, synthesis, and biological evaluation of novel 2-(furan-2-yl)naphthalen-1-ol derivatives as potent and selective antibreast cancer agents.

22

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antitumor agents. 254. Synthesis and biological evaluation of novel neo-tanshinlactone analogues as potent anti-breast cancer agents

23

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza

24

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antitumor agents. 272. Structure-activity relationships and in vivo selective anti-breast cancer activity of novel neo-tanshinlactone analogues.

25

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antitumor agents 278. 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs as potent in vitro anti-cancer agents

26

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents

27

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Novel coumarin derivatives as potential antidyslipidemic agents

28

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Synthesis of novel benzocoumarin derivatives as lipid lowering agents

29

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents

30

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Chalcones: an update on cytotoxic and chemoprotective properties

32

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Clinical study of Photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma

35

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Cell growth inhibitory action of an unusual labdane diterpene, 13-epi-sclareol in breast and uterine cancers in vitro

37

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.

38

1 reference

10.1016/J.BMCL.2010.09.040

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.040

3 August 2024

Identifiers

10.1016/J.BMCL.2010.09.040

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33720137&oldid=2219915936"